**Core Concept**
The volume of infarcted myocardial tissue in acute myocardial infarction (AMI) is best assessed by imaging techniques that visualize myocardial perfusion and viability, or by biomarkers that reflect necrotic tissue. Among the options, both thallium scan and CPK-MB levels provide measurable data related to infarct size, though through different mechanisms.

**Why the Correct Answer is Right**
Thallium scan (Option d) is a nuclear imaging technique that detects regional myocardial perfusion defects, directly visualizing the extent of ischemic and infarcted myocardium. It provides a quantitative measure of infarct volume based on uptake patterns in the heart. CPK-MB (Option c) is a cardiac-specific enzyme released into the bloodstream upon myocardial cell damage; elevated levels correlate with the size of the infarcted area, especially in the early stages. Thus, both are clinically used to estimate infarct volume. Echocardiography (Option a) can assess wall motion abnormalities and infer infarct size but is less precise than imaging or biomarkers. ECG (Option b) detects electrical changes but cannot quantify infarct volume.

**Why Each Wrong Option is Incorrect**
Option A: Echocardiography is not specific for detecting the *volume* of infarcted tissue; it provides indirect estimates based on wall motion, which can be misleading due to technical limitations or non-specific changes.
Option B: ECG shows ST elevation or Q waves indicating AMI but cannot quantify infarct size or detect the actual volume of damaged tissue.

**Clinical Pearl / High-Yield Fact**
In AMI, CPK-MB and thallium scan are both high-yield tools for estimating infarct size—CPK-MB for early biochemical detection and thallium scan for precise anatomical assessment. Always remember: **CPK-MB correlates with infarct size, but thallium scan gives direct visualization.**

✓ Correct Answer: D. ad